Objectives: The prevalence of hepatocellular carcinoma (HCC) in primary biliary cirrhosis (PBC) is not well established, as some reports suggest a low risk, whereas others indicate that HCC may be no less frequent than in other types of cirrhosis. Methods: We compared the incidence of HCC in...
NO has broad and sometimes dichotomous roles in cancer. The effects of NO in tumours depend on the type and localization of NOS isoforms, concentration and duration of NO exposure, and cellular sensitivity to NO. Hepatocellular carcinoma (HCC) is a common and lethal disease for which no effecti...
Improvements in prostate cancer diagnosis and treatment have resulted in a decreasing age-adjusted death rate. But improved diagnostic tools have not deliv... KF Sullivan,ED Crawford - 《Therapeutic Advances in Urology》 被引量: 55发表: 2009年 Higgs boson phenomenology and VEV shift in the RS ...
7.A new target in future treatment of liver cancer-liver cancer stem cells未来肝癌治疗的新靶点-肝癌干细胞 8.Intracellular Expression of Anti Hepatocellular Carcinoma (HCC) Single Chain Antibody (scFv) in HCC Cell Line;细胞内表达抗肝癌单链抗体对肝癌细胞的作用 9.The Expression of STAT 5 in huma...
cancer stemness in HCC cells,98indicating a positive role for inflammatory CXCL11 in HCC cancer stemness and progression. Another study of chemokines in HCC found that CCL20 was overexpressed in HCC and that a high serum CCL20 level was associated with poorer disease-free and overall survival...
Since HCC is a complex multi-step process influenced by many factors for its initiation and progression, therapeutic interventions are challenging for this disease. With the rising incidence of HCC and high morbidity and mortality rates associated with this cancer, there is an urgent need to develop...
such as surgical resection,are not eligible to be conducted.In recent years,non-resection therapies for unresectable HCC have been developed,which can control tumor growth,prolong survival time and improve quality of life.This review covers the current status and progress of non-resection therapies ...
Nature Reviews Disease Primers volume 2, Article number: 16018 (2016) Cite this article 22k Accesses 96 Altmetric Metrics details Abstract Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular ...
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Most patients still present late in the course of the disease so that curative therapy is rarely possible. Strategies developed to improve the prognosis include primary prevention, directed at the underlying liver diseases,...
Hepatocellular carcinoma (HCC) has become a leading cause of cancer-related death, making the elucidation of its underlying mechanisms an urgent priority. Inflammation is an adaptive response to infection and tissue injury under strict regulations. When